| Antibiotic class |
Cases (n= 38) |
Controls (n=38) |
p value |
| Glicopeptydes, n (%) |
11 (28,95) |
4 (10,53%) |
0,04 |
| Glicopeptydes-days |
13,54 ± 11,55 |
7,5 ± 8,27 |
0,76 |
| Antifungines, n (%) |
7 (18,42) |
2 (5,26) |
0,07 |
| Carbapenems, n (%) |
8 (21,05) |
2 (5,26) |
0,04 |
| Carbapenems-days |
17,37 ± 12,55 |
20 ± 5,66 |
0,69 |
| β-lactams, n (%) |
26 (68,42) |
23 (60,53) |
0,16 |
| β-lattams-days |
8,42 ± 10,27 |
8,65 ± 7,26 |
0,94 |
| Fluoroquinolones, n (%) |
3 (7,89) |
6 (15,79) |
0,17 |
| Fluoroquinolones-days |
12,83 ± 10,04 |
7,5 ± 7,29 |
0,20 |
| Aminoglycosides, n (%) |
10 (26,32) |
2 (5,26) |
0,02 |
| Aminoglycosides-days |
11,2 ± 10,84 |
13 ± 8,72 |
0,66 |
| Cephalosporins, n (%) |
3 (7,89) |
3 (7,89) |
1 |
| Cephalosporins-days |
5,67 ± 6,43 |
12 ± 9,16 |
0,08 |
| N° of administered antibiotic classes |
2,03 ± 1,88 |
1,18 ± 1,56 |
0,01 |
|
